Cytarabine Kabi is a pyrimidine nucleoside analogue drug used in chemotherapy.
Strength is denoted by disposable cap color.
Cytarabine Kabi 100 mg/1 ml
Cytarabine Kabi 500 mg/5 ml
Cytarabine Kabi 1 g/10 ml
Cytarabine Kabi 2 g/20 ml
Cytarabine Kabi is indicated for the treatment of patients with remission in acute myeloid leukemia in adults and for other acute leukemias of adults and children.
Please note that this product may not be available in all countries due to different registration status.
Additionally, approved indications, contraindications, side effects, warnings and all over product characteristics may differ between countries. Therefore, always the text of the nationally registered and approved product information is binding! Furthermore, country specific regulatory considerations affect the information we can provide on our products.
If you require any information please contact your local organization.